# FDA Inspection 883899 - ALS Group USA, Corp - June 18, 2014

Source: https://www.globalkeysolutions.net/records/fda_inspections/als-group-usa-corp/c2293740-f625-4aaf-a2bd-d9b005fdb74e
Source feed: FDA_Inspections

> FDA Inspection 883899 for ALS Group USA, Corp on June 18, 2014. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 883899
- Company Name: ALS Group USA, Corp
- Inspection Date: 2014-06-18
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1207264 - 2023-06-05](https://www.globalkeysolutions.net/records/fda_inspections/als-group-usa-corp/76cf3ca1-c158-4027-82f2-8661490b459e)
- [FDA Inspection 1041299 - 2018-02-16](https://www.globalkeysolutions.net/records/fda_inspections/als-group-usa-corp/ba612440-473d-46a8-b310-6574e9948d61)
- [FDA Inspection 770574 - 2012-03-01](https://www.globalkeysolutions.net/records/fda_inspections/als-group-usa-corp/b8c94891-18b7-462c-b46a-b88b817f5af4)
- [FDA Inspection 643202 - 2010-01-28](https://www.globalkeysolutions.net/records/fda_inspections/als-group-usa-corp/025a54b8-a562-4985-926f-ff089bbdae39)

Company: https://www.globalkeysolutions.net/companies/als-group-usa-corp/6d3305d4-76a4-4d57-8ed6-1e636d486309

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c